Year All20242023202220212020201920182017201620152014 Abivax announces plans to conduct registered public offering in the United States August 10, 2023 Read More Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors July 11, 2023 Read More Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023 June 15, 2023 Read More Abivax stock included in MSCI indexes June 08, 2023 Read More Abivax appoints Ida Hatoum as Chief People Officer June 06, 2023 Read More Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting June 06, 2023 Read More Abivax announces its ordinary and extraordinary general meeting of June 5, 2023, and the availability of the preparatory documents May 15, 2023 Read More Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel” May 04, 2023 Read More Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients May 02, 2023 Read More Abivax postpones the publication of its 2023 Universal Registration Document April 28, 2023 Read More
Abivax announces plans to conduct registered public offering in the United States August 10, 2023 Read More
Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors July 11, 2023 Read More
Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023 June 15, 2023 Read More
Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting June 06, 2023 Read More
Abivax announces its ordinary and extraordinary general meeting of June 5, 2023, and the availability of the preparatory documents May 15, 2023 Read More
Abivax publishes Universal Registration Document 2023 “Document d’Enregistrement Universel” May 04, 2023 Read More
Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients May 02, 2023 Read More
Abivax postpones the publication of its 2023 Universal Registration Document April 28, 2023 Read More
